Home LiteratureArticle Details
PMID: 10888611 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues.

Journal of virology ·Vol. 74 ·No. 15 ·2000-08-00 ·Pages 6734-40

Cimarelli A, Luban J

Abstract

The human immunodeficiency virus type 1 (HIV-1) Gag polyprotein is sufficient for assembly and release of virion-like particles from the plasma membrane. To promote assembly, the Gag polyprotein must polymerize to form a shell that lines the inner membrane of nascent virions. Several techniques have been used to functionally map the domain required for Gag polymerization (the I domain). Among these methods, isopycnic centrifugation has been used under the assumption that changes in virion density reflect impairment in Gag-Gag interaction. If virion density is determined by efficient Gag-Gag interaction, then mutation of basic residues in the nucleocapsid (NC) domain should disrupt virion density, since these residues constitute the I domain. However, we have previously shown that simultaneous disruption of up to 10 HIV-1 NC basic residues has no obvious effect on virion density. To rule out the possibility that HIV-1 NC basic residues other than those previously mutated might be important for virion density, mutations were introduced at the remaining sites and the ability of these mutations to affect Gag-Gag interaction and virion density was analyzed. Included in our analysis is a mutant in which all NC basic residues are replaced with alanine. Our results show that disruption of HIV-1 NC basic residues has an enormous effect on Gag-Gag interaction but only a minimal effect on the density of those virions that are still produced. Therefore, the determinants of the I domain and of virion density are genetically distinguishable.

MeSH Terms
Amino Acid Sequence Centrifugation, Isopycnic Gene Products, gag/chemistry,genetics,metabolism HIV-1/genetics,physiology HeLa Cells Humans Jurkat Cells Molecular Sequence Data Mutation Nucleocapsid Proteins/chemistry,genetics,metabolism Transfection Virion/physiology Virus Assembly Virus Replication
Chemicals
Gene Products, gag Nucleocapsid Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cimarelli A
Department of Microbiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
Luban J
References (25)
25 references, click to expand
  1. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
    J Virol. 1999 Jul;73(7):5388-401 PMID: 10364286
  2. Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.
    Virology. 1999 Jan 20;253(2):259-70 PMID: 9918884
  3. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
    J Virol. 1999 Oct;73(10):8527-40 PMID: 10482606
  4. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
    J Virol. 2000 Apr;74(7):3046-57 PMID: 10708419
  5. Hydrodynamic diameters of RNA tumor viruses. Studies by laser beat frequency light scattering spectroscopy of avian myeloblastosis and Rauscher murine leukemia viruses.
    Biochemistry. 1975 Jan 14;14(1):134-41 PMID: 162827
  6. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level.
    J Immunol. 1984 Jul;133(1):123-8 PMID: 6327821
  7. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence.
    Proc Natl Acad Sci U S A. 1988 Nov;85(22):8420-4 PMID: 3141927
  8. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface.
    Cell. 1992 Feb 7;68(3):533-44 PMID: 1531449
  9. Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.
    J Virol. 1993 Apr;67(4):2266-75 PMID: 8445731
  10. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.
    Cell. 1993 Jun 18;73(6):1067-78 PMID: 8513493
  11. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
    J Virol. 1993 Nov;67(11):6487-98 PMID: 8411352
  12. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.
    Proc Natl Acad Sci U S A. 1994 May 10;91(10):4594-8 PMID: 8183954
  13. Specificity and sequence requirements for interactions between various retroviral Gag proteins.
    J Virol. 1994 Aug;68(8):5300-5 PMID: 8035530
  14. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
    J Virol. 1994 Dec;68(12):8017-27 PMID: 7966591
  15. Specific incorporation of cyclophilin A into HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):359-62 PMID: 7969494
  16. Functional association of cyclophilin A with HIV-1 virions.
    Nature. 1994 Nov 24;372(6504):363-5 PMID: 7969495
  17. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.
    J Virol. 1995 Apr;69(4):2366-77 PMID: 7884882
  18. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
    J Virol. 1995 Jun;69(6):3407-19 PMID: 7745687
  19. Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.
    J Virol. 1996 Aug;70(8):5106-14 PMID: 8764018
  20. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity.
    J Virol. 1996 Oct;70(10):6607-16 PMID: 8794295
  21. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.
    J Virol. 1998 Apr;72(4):2723-32 PMID: 9525590
  22. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.
    J Virol. 1998 Nov;72(11):9034-44 PMID: 9765448
  23. HIV-1 gag proteins: diverse functions in the virus life cycle.
    Virology. 1998 Nov 10;251(1):1-15 PMID: 9813197
  24. The role of nucleocapsid of HIV-1 in virus assembly.
    Virology. 1998 Nov 10;251(1):141-57 PMID: 9813210
  25. Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy.
    J Virol. 1999 Aug;73(8):7050-5 PMID: 10400808
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2000-08-00
Pages
6734-40
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC112189
Subset
IM
Grants
NIAID NIH HHS · P30 AI042848 · United States
NIAID NIH HHS · R01 AI041857 · United States
NIAID NIH HHS · AI41857 · United States
NIAID NIH HHS · P30 AI42848 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com